These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24312537)

  • 1. Use of anti-Aedes aegypti salivary extract antibody concentration to correlate risk of vector exposure and dengue transmission risk in Colombia.
    Londono-Renteria B; Cardenas JC; Cardenas LD; Christofferson RC; Chisenhall DM; Wesson DM; McCracken MK; Carvajal D; Mores CN
    PLoS One; 2013; 8(12):e81211. PubMed ID: 24312537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
    Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
    Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.
    Ndille EE; Dubot-Pérès A; Doucoure S; Mouchet F; Cornelie S; Sidavong B; Fournet F; Remoue F
    Trop Med Int Health; 2014 May; 19(5):576-80. PubMed ID: 24641205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
    Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
    Elanga Ndille E; Doucoure S; Poinsignon A; Mouchet F; Cornelie S; D'Ortenzio E; DeHecq JS; Remoue F
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005109. PubMed ID: 27906987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.
    Fustec B; Phanitchat T; Aromseree S; Pientong C; Thaewnongiew K; Ekalaksananan T; Cerqueira D; Poinsignon A; Elguero E; Bangs MJ; Alexander N; Overgaard HJ; Corbel V
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009440. PubMed ID: 34043621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to
    Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
    Front Immunol; 2024; 15():1368066. PubMed ID: 38751433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections.
    Cardenas JC; Drame PM; Luque-Burgos KA; Berrio JD; Entrena-Mutis E; González MU; Carvajal DJ; Gutiérrez-Silva LY; Cardenas LD; Colpitts TM; Mores CN; Londono-Renteria B
    PLoS One; 2019; 14(1):e0208455. PubMed ID: 30601814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus.
    Luplertlop N; Surasombatpattana P; Patramool S; Dumas E; Wasinpiyamongkol L; Saune L; Hamel R; Bernard E; Sereno D; Thomas F; Piquemal D; Yssel H; Briant L; Missé D
    PLoS Pathog; 2011 Jan; 7(1):e1001252. PubMed ID: 21249175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.
    Fontaine A; Pascual A; Orlandi-Pradines E; Diouf I; Remoué F; Pagès F; Fusaï T; Rogier C; Almeras L
    PLoS One; 2011; 6(12):e29107. PubMed ID: 22195000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus.
    da Moura AJ; de Melo Santos MA; Oliveira CM; Guedes DR; de Carvalho-Leandro D; da Cruz Brito ML; Rocha HD; Gómez LF; Ayres CF
    Parasit Vectors; 2015 Feb; 8():114. PubMed ID: 25888847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue viruses binding proteins from Aedes aegypti and Aedes polynesiensis salivary glands.
    Cao-Lormeau VM
    Virol J; 2009 Mar; 6():35. PubMed ID: 19320997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement.
    Schmid MA; Glasner DR; Shah S; Michlmayr D; Kramer LD; Harris E
    PLoS Pathog; 2016 Jun; 12(6):e1005676. PubMed ID: 27310141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dengue-2 virus infection on protein expression in the salivary glands of Aedes aegypti mosquitoes.
    Chisenhall DM; Londono BL; Christofferson RC; McCracken MK; Mores CN
    Am J Trop Med Hyg; 2014 Mar; 90(3):431-7. PubMed ID: 24445208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of early dengue virus infection in mice as modulated by Aedes aegypti probing.
    McCracken MK; Christofferson RC; Chisenhall DM; Mores CN
    J Virol; 2014 Feb; 88(4):1881-9. PubMed ID: 24198426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aedes aegypti D7 Saliva Protein Inhibits Dengue Virus Infection.
    Conway MJ; Londono-Renteria B; Troupin A; Watson AM; Klimstra WB; Fikrig E; Colpitts TM
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004941. PubMed ID: 27632170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus replicates and accumulates in Aedes aegypti salivary glands.
    Raquin V; Lambrechts L
    Virology; 2017 Jul; 507():75-81. PubMed ID: 28431281
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Olajiga OM; Marin-Lopez A; Cardenas JC; Gutierrez-Silva LY; Gonzales-Pabon MU; Maldonado-Ruiz LP; Worges M; Fikrig E; Park Y; Londono-Renteria B
    Front Epidemiol; 2022; 2():1002857. PubMed ID: 38455331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study.
    Londono-Renteria B; Drame PM; Weitzel T; Rosas R; Gripping C; Cardenas JC; Alvares M; Wesson DM; Poinsignon A; Remoue F; Colpitts TM
    Parasit Vectors; 2015 Oct; 8():533. PubMed ID: 26464073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive advantage of a dengue 4 virus when co-infecting the mosquito Aedes aegypti with a dengue 1 virus.
    Vazeille M; Gaborit P; Mousson L; Girod R; Failloux AB
    BMC Infect Dis; 2016 Jul; 16():318. PubMed ID: 27390932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.